Certified by Founder Lodge 
                                        
                                        Agent Capital
 
                                                 United States  -  Waltham, MA 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $123,000,000
                                            8 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need. Our investment areas of focus are new products and technologies f
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Flare Therapeutics | 
                                                            March, 23 ,2023 | Series B | $123,000,000 | 
   Orbital Therapeutics | 
                                                            April, 27 ,2023 | Series A | $270,000,000 | 
   Foresight Diagnostics Inc. | 
                                                            April, 28 ,2023 | Series B | $58,750,000 | 
   Star Therapeutics | 
                                                            September, 05 ,2023 | Series C | $90,000,000 | 
   Jana Care | 
                                                            November, 09 ,2023 | Unknown | $6,000,000 | 
   Cerevance | 
                                                            April, 26 ,2024 | Series B | $47,000,000 | 
   TRexBio | 
                                                            November, 14 ,2024 | Series B | $84,000,000 | 
   Hone Health | 
                                                            January, 29 ,2025 | Series A | $33,000,000 | 
                                                
  Flare Therapeutics
  Orbital Therapeutics
  Foresight Diagnostics Inc.
  Star Therapeutics
  Jana Care
  Cerevance
  TRexBio
  Hone Health
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)